These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36109362)

  • 1. Positive and negative impact of anti-reflux mucosal intervention on gastroesophageal reflux disease.
    Chou CK; Chen CC; Chen CC; Wu JF; Liao WC; Chiu HM; Wang HP; Wu MS; Tseng PH
    Surg Endosc; 2023 Feb; 37(2):1060-1069. PubMed ID: 36109362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases.
    Sumi K; Inoue H; Kobayashi Y; Iwaya Y; Abad MRA; Fujiyoshi Y; Shimamura Y; Ikeda H; Onimaru M
    Dig Endosc; 2021 Mar; 33(3):347-354. PubMed ID: 32415898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.
    Akiyama J; Hosaka H; Kuribayashi S; Moriyasu S; Hisada Y; Okubo H; Watanabe K; Imbe K; Nagata N; Kojima Y; Yokoi C; Uemura N; Shimoyama Y; Kawamura O; Yamada M; Kusano M
    Digestion; 2020; 101(2):174-183. PubMed ID: 30897577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
    Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M
    Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective Outcomes of an Extended Anti-reflux Mucosectomy in the Treatment of PPI-Dependent Gastroesophageal Reflux Disease (with Video).
    He J; Yin Y; Tang W; Jiang J; Gu L; Yi J; Yan L; Chen S; Wu Y; Liu X
    J Gastrointest Surg; 2022 Aug; 26(8):1566-1574. PubMed ID: 35776296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of endoluminal gastroplication in Japanese patients with proton pump inhibitor-resistant, non-erosive esophagitis.
    Tokudome K; Funaki Y; Sasaki M; Izawa S; Tamura Y; Iida A; Ogasawara N; Konagaya T; Tokura Y; Kasugai K
    World J Gastroenterol; 2012 Nov; 18(41):5940-7. PubMed ID: 23139611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal physiologic profiles within erosive esophagitis in China: Predominantly low-grade esophagitis with low reflux burden.
    Zhang M; Tan N; Li Y; Chen M; Xiao Y
    Neurogastroenterol Motil; 2019 Dec; 31(12):e13702. PubMed ID: 31407469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.
    Matsumura T; Arai M; Suzuki T; Hoppo T; Seki Y; Kasamatsu S; Ishigami H; Ishikawa K; Okimoto K; Akizue N; Maruoka D; Nakagawa T; Odaka T; Okamoto Y; Kato N
    Esophagus; 2020 Jul; 17(3):339-347. PubMed ID: 31982992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short and long term effect of anti-reflux mucosectomy with cap-assisted endoscopic mucosal resection for refractory gastroesophageal disease.
    Lee YS; Kim JH; Yon DK; Yoo IK
    Surg Endosc; 2024 Apr; 38(4):2180-2187. PubMed ID: 38448622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antireflux mucosal intervention (ARMI) procedures for refractory gastroesophageal reflux disease: a systematic review and meta-analysis.
    Yeh JH; Lee CT; Hsu MH; Lin CW; Hsiao PJ; Chen CL; Wang WL
    Therap Adv Gastroenterol; 2022; 15():17562848221094959. PubMed ID: 35509424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic work-up of GERD.
    Vela MF
    Gastrointest Endosc Clin N Am; 2014 Oct; 24(4):655-66. PubMed ID: 25216910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.
    Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M
    World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study (with video).
    Patil G; Dalal A; Maydeo A
    Dig Endosc; 2020 Jul; 32(5):745-752. PubMed ID: 31834663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study on anti-reflux mucoplasty: Advancing endoscopic anti-reflux therapy for gastroesophageal reflux disease.
    Inoue H; Yamamoto K; Shimamura Y; Azuma D; Ushikubo K; Okada H; Kimoto Y; Nishikawa Y; Tanaka I; Tanabe M; Onimaru M; Navarro MJ
    Dig Endosc; 2024 Jun; 36(6):690-698. PubMed ID: 37899073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease.
    Visaggi P; Del Corso G; Gyawali CP; Ghisa M; Baiano Svizzero F; Stefani Donati D; Venturini A; Savarino V; Penagini R; Zeki S; Bellini M; Savarino EV; de Bortoli N
    Am J Gastroenterol; 2023 May; 118(5):794-801. PubMed ID: 36633477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored therapy for the refractory GERD patients by combined multichannel intraluminal impedance-pH monitoring.
    Xiao Y; Liang M; Peng S; Zhang N; Chen M
    J Gastroenterol Hepatol; 2016 Feb; 31(2):350-4. PubMed ID: 26202002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of proton pump inhibition on acid, weakly acid and weakly alkaline gastro-esophageal reflux in children.
    Turk H; Hauser B; Brecelj J; Vandenplas Y; Orel R
    World J Pediatr; 2013 Feb; 9(1):36-41. PubMed ID: 23389331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
    Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
    Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.